We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Ready to Shut Door Hard on NDAs, ANDAs for Protein Products
FDA Ready to Shut Door Hard on NDAs, ANDAs for Protein Products
Makers of protein-based biologics approved under the NDA pathway will lose all exclusivity rights in four years, and any NDA or ANDA that hasn’t been approved by March 23, 2020, will be voided.